Search

everythinglearnresearchcommunity

for

Search:↓

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

Certain skin conditions in women are linked to higher risks of metabolic syndrome and type 2 diabetes due to hormone imbalances.

New regenerative medicine-based therapies for hair loss look promising but need more clinical validation.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Genetic mutations can affect female sexual development, requiring personalized medical care.

New compounds may soon be tested to treat excessive hair growth in women.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

Nutrease powder, a high-protein, low-carb supplement, can help manage Polycystic Ovary Syndrome symptoms, regulate periods, improve ovulation, and restore fertility.

PCOS is a common hormonal disorder in women that can lead to serious health problems.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Athletes use steroids to enhance performance despite health risks and legal issues, and education on their dangers is needed.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Low testosterone does not prevent prostate cancer in men with type 1 diabetes.

ADAM17 could be a potential target for treating PCOS.